Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 6,406,000 | 5,823,000 | 5,491,000 | 6,417,000 | 5,340,000 |
| Cost of Goods | 1,351,000 | 1,063,000 | 1,129,000 | 1,637,000 | 1,153,000 |
| Gross Profit | 5,055,000 | 4,760,000 | 4,362,000 | 4,780,000 | 4,187,000 |
| Operating Expenses | 4,298,000 | 4,267,000 | 3,265,000 | 3,703,000 | 3,336,000 |
| Operating Income | 757,000 | 493,000 | 1,097,000 | 1,077,000 | 851,000 |
| Interest Expense | 353,000 | 361,000 | 367,000 | 337,000 | 364,000 |
| Other Income | 5,000 | 9,000 | 28,000 | -10,000 | -10,000 |
| Pre-tax Income | 409,000 | 141,000 | 758,000 | 730,000 | 477,000 |
| Income Tax | 129,000 | 34,000 | 195,000 | -279,000 | 71,000 |
| Net Income Continuous | 280,000 | 107,000 | 563,000 | 1,009,000 | 406,000 |
| Minority Interests | -19,000 | -23,000 | -30,000 | -25,000 | -25,000 |
| Net Income | $299,000 | $130,000 | $593,000 | $1,034,000 | $431,000 |
| EPS Basic Total Ops | 0.12 | 0.05 | 0.24 | 0.41 | 0.17 |
| EPS Basic Continuous Ops | 0.11 | 0.04 | 0.22 | 0.40 | 0.16 |
| EPS Diluted Total Ops | 0.12 | 0.05 | 0.24 | 0.41 | 0.17 |
| EPS Diluted Continuous Ops | 0.11 | 0.04 | 0.22 | 0.40 | 0.16 |
| EBITDA(a) | $1,473,000 | $1,220,000 | $1,773,000 | $2,739,000 | $1,549,000 |